Algorithm for the development of systemic pharmaceutical care messages aimed at clinicians as exemplified by community – acquired pneumonia
Original Article, Pol J Public Health 2019;129(3): 75-77
Andriy Zimenkovsky, Myroslava Sekh, Ulyana Yanyshyn
Department of Clinical Pharmacy, Pharmacotherapy and Medical Standardization, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
© 2019 Medical University of Lublin. This is an open access article distributed under the Creative Commons Attribution-NonComercial-No Derivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/)
Introduction. Medication errors, which are increasing in number every year worldwide, represent a significant part of the development of adverse pharmacotherapy results, what creates the need to develop additional tools and means that could effectively provide mechanisms of rational pharmacotherapy.
Aim. Development of an algorithm for the creation of systemic messages of pharmaceutical care aimed at clinicians, concerning specific nosology.
Material and methods. The object of the study was the medical documentation of 540 patients of the therapeutic unit who were diagnosed with community-acquired pneumonia. The quality analysis of the prescribed pharmacotherapy was conducted according to our modified European Classification Scheme PCNE V5.01 for detection of drug-related problems (DRP).
Results. As many as 8386 DRPs were detected in the analyzed 540 medical prescriptions. Based on them, 276 systemic pharmaceutical care messages were formed, which are related to nosology in general and aimed at clinicians.
Conclusions. According to the results of the pharmacotherapy quality assessment of 540 patients, in particular those with community-acquired pneumonia, 8386 DRPs were identified, which confirmed our scientific hypothesis regarding its low quality. The proposed algorithm for the development of systemic pharmacy care messages aimed at clinicians may serve as an additional tool that could effectively provide rational pharmacotherapy mechanisms.
Keywords: quality of pharmacotherapy, community-acquired pneumonia, pharmaceutical care.